You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 22, December 10, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Adverse Effects
 •Alert me on articles by topic

Benzodiazepine Use and Risk of Mortality in Individuals Aged 85 Years or Older

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Although benzodiazepines are indicated for only a limited number of psychiatric disorders, they are the most commonly prescribed psychotropic drugs in elderly individuals.1 Use of benzodiazepines in this population has been related to poor outcomes such as hip fractures, motor vehicle crashes, and suicide,2-4 but it remains unclear to what extent use of benzodiazepines increases the risk of mortality in elderly individuals.5 We investigated the relationship between benzodiazepine use and mortality in a prospective study among individuals aged 85 years or older.

Methods

The Leiden 85-plus Study is a prospective population-based study of all inhabitants of Leiden, the Netherlands, aged 85 years or older. Between September 1, 1997, and September 1, 1999, the study enrolled 599 participants (participation rate = 87%).6 Participants were visited annually at home for face-to-face interviews. The medical ethical committee of the Leiden University Medical Center approved the study and all participants provided oral . . . [Full Text of this Article]

David J. Vinkers, MD, MA; Jacobijn Gussekloo, MD, PhD
Department of General Internal Medicine

Roos C. van der Mast, MD, PhD; Frans G. Zitman, MD, PhD
Department of Psychiatry

Rudi G. J. Westendorp, MD, PhD
Department of General Internal Medicine
Leiden University Medical Center
Leiden, the Netherlands



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The medical management of depression.
Mann
NEJM 2005;353:1819-1834.
FULL TEXT  

Tying It Together
Chen
Sci Aging Knowl Environ 2004;2004:nf23-23.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.